Evidence map›Paper›PMID 17448169›Full record

ArticleJournal of applied microbiology2007

In vivo gene delivery and expression by bacteriophage lambda vectors.

H A Lankes, C N Zanghi, K Santos, C Capella, C M P Duke, S Dewhurst

Open access · bronzeAbstract read
In one paragraph

Article in Journal of applied microbiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Bacteriophage-Mediated Cancer Gene Therapy.International journal of molecular sciences · 2022
    Review
  7. Phage engineering and the evolutionary arms race.Current opinion in biotechnology · 2021
    Review
  8. Article
  9. Enhancement of Photodynamic Cancer Therapy by Physical and Chemical Factors.Angewandte Chemie (International ed. in English) · 2019
    Review
  10. Article
  11. Review
  12. Review
  13. Bacteriophages and medical oncology: targeted gene therapy of cancer.Medical oncology (Northwood, London, England) · 2014
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

H A LankesDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.
C N Zanghi
K Santos
C Capella
C M P Duke
S Dewhurst
University of Rochester Medical Center · US

Funding

University of Rochester Mentoring Environment: Nurturing Training Opportunities in Research (UR-MENTOR)T32GM007356 · NIGMS · UNIVERSITY OF ROCHESTER · PI O'BANION, M. KERRY · 1985 to 2023
$15.1M
HSV-1 Amplicon Vectors for HIV Vaccine DeliveryP01AI056356 · NIAID · UNIVERSITY OF ROCHESTER · PI KEEFER, MICHAEL C · 2003 to 2007
$11.6M
Training in Microbial PathogenesisT32AI007362 · NIAID · UNIVERSITY OF ROCHESTER · PI IGLEWSKI, BARBARA H. · 1990 to 2010
$2.6M
Bacteriophage gene transfer for HIV vaccine deliveryR21AI058791 · NIAID · UNIVERSITY OF ROCHESTER · PI DEWHURST, STEPHEN · 2005 to 2006
$463k
Phage Vectors for HIV Vaccine DevelopmentF31AI054330 · NIAID · UNIVERSITY OF ROCHESTER · PI SANTOS, KATHLYN · 2003 to 2006
$162k
NIAID NIH HHS F31 AI054330NIAID NIH HHS P01 AI056356NIAID NIH HHS R21 AI058791NIAID NIH HHS T32 AI007362NIGMS NIH HHS T32 GM007356NIGMS NIH HHS T32 GM07356
6 · The paper itself

Abstract

aimsBacteriophage vectors have potential as gene transfer and vaccine delivery vectors because of their low cost, safety and physical stability. However, little is known concerning phage-mediated gene transfer in mammalian hosts. We therefore performed experiments to examine phage-mediated gene transfer in vivo. METHODS AND

resultsMice were inoculated with recombinant lambda phage containing a mammalian expression cassette encoding firefly luciferase (luc). Efficient, dose-dependent in vivo luc expression was detected, which peaked within 24 h of delivery and declined to undetectable levels within a week. Display of an integrin-binding peptide increased cellular internalization of phage in vitro and enhanced phage-mediated gene transfer in vivo. Finally, in vivo depletion of phagocytic cells using clodronate liposomes had only a minor effect on the efficiency of phage-mediated gene transfer.

conclusionsUnmodified lambda phage particles are capable of transducing mammalian cells in vivo, and may be taken up -- at least in part -- by nonphagocytic mechanisms. Surface modifications that enhance phage uptake result in more efficient in vivo gene transfer. SIGNIFICANCE AND IMPACT OF THE STUDY: These experiments shed light on the mechanisms involved in phage-mediated gene transfer in vivo, and suggest new approaches that may enhance the efficiency of this process.

Indexed as

Genetic VectorsGene Transfer TechniquesAnimalsBacteriophage lambdaGene ExpressionMiceMice, Inbred BALB CVaccinesVaccines

Identifiers

PMID17448169
PMCPMC2063594
OpenAlexW2051595264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.